SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
15-Oct-24 8:31 AM View: | Aprea Therapeutics, Inc. (APRE) | 11-Oct-24 | Market Purchase | 10,000 | $2.68 | $26,800.00 | 29% 34.73K to 44.73K | 4% |
14-Mar-24 8:53 PM View: | Aprea Therapeutics, Inc. (APRE) | 13-Mar-24 | Purchase | 6,860 | $7.29 | $50,009.40 | 26% 26.82K to 33.69K | |
25-Sep-23 5:03 PM View: | Aptose Biosciences Inc. (APTO) | 22-Sep-23 | Purchase | 17,000 | $3.14 | $53,380.00 | 100% 0 to 17.0K | |
24-Aug-23 9:48 PM View: | Aprea Therapeutics, Inc. (APRE) | 23-Aug-23 | Grant | 500 | -- | -- | 2% 26.32K to 26.82K | |
08-Jun-23 4:34 PM View: | Aprea Therapeutics, Inc. (APRE) | 07-Jun-23 | Purchase | 6,029 | $3.68 | $22,192.10 | 30% 20.3K to 26.32K | |
08-Jun-23 4:34 PM View: | Aprea Therapeutics, Inc. (APRE) | 06-Jun-23 | Purchase | 4,068 | $3.63 | $14,764.40 | 25% 16.23K to 20.3K | |
01-Aug-22 5:06 PM View: | Aprea Therapeutics, Inc. (APRE) | 28-Jul-22 | Grant | 5,995 | -- | -- | 2% 318.58K to 324.57K | |
19-May-22 4:31 PM View: | Aprea Therapeutics, Inc. (APRE) | 18-May-22 | Private Purchase | 50,000 | $0.71 | $35,500.00 | 19% 268.58K to 318.58K | |
01-Jul-21 7:00 PM View: | Aprea Therapeutics, Inc. (APRE) | 30-Jun-21 | Grant | 4,610 | -- | -- | 2% 263.97K to 268.58K | |
07-Oct-19 7:33 PM View: | Aprea Therapeutics, Inc. (APRE) | 07-Oct-19 | Option Exercise | 263,970 | $0.07 | $18,477.90 | 100% 0 to 263.97K |